0001358403-19-000007.txt : 20190104
0001358403-19-000007.hdr.sgml : 20190104
20190104160207
ACCESSION NUMBER: 0001358403-19-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190102
FILED AS OF DATE: 20190104
DATE AS OF CHANGE: 20190104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spencer David M.
CENTRAL INDEX KEY: 0001627362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 19509946
MAIL ADDRESS:
STREET 1: C/O BELLICUM PHARMACEUTICALS, INC.
STREET 2: 2130 W. HOLCOMBE BLVD., STE. 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
wf-form4_154663570769533.xml
FORM 4
X0306
4
2019-01-02
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001627362
Spencer David M.
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
0
1
0
0
Chief Technology Officer
Common Stock
2019-01-02
4
M
0
2500
A
92439
D
Common Stock
2019-01-02
4
F
0
942
3.33
D
91497
D
Common Stock
2019-01-03
4
M
0
1562
A
93059
D
Common Stock
2019-01-03
4
F
0
589
3.20
D
92470
D
Restricted Stock Units
2019-01-02
4
M
0
2500
0
D
Common Stock
2500.0
7500
D
Restricted Stock Units
2019-01-03
4
M
0
1562
0
D
Common Stock
1562.0
3125
D
Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer common stock.
Represents the number of shares withheld by and surrendered to the Issuer on January 2, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 2, 2018 for 10,000 shares.
Represents the number of shares withheld by and surrendered to the Issuer on January 3, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 3, 2017 for 6,250 shares.
The RSUs vest in four equal annual installments beginning on January 2, 2019.
The RSUs vest in four equal annual installments beginning on January 3, 2018.
/s/ Rosemary Y. Williams, Attorney-in-Fact
2019-01-04